Asset Publisher Asset Publisher

Precision medicine research requires access to sufficient numbers of samples and data that properly cover the broad spectrum of disease sub-entities relevant for targeted therapies. To address this demand samples and data from different biobanks in different countries must be suitable for integrated analyses. This is only possible if samples and data meet common quality criteria.

Data and quality management become increasingly important, and biobanks will develop from a sample provider to a data and knowledge provider. ...

Read more: Original article

(C) BBMRI.at partner Biobank Graz  (Medical University of Graz)